Skip to main content

Table 4 Compliance by age in patients with Crohn’s disease, sanitary district of Lleida (Spain) 2016

From: Compliance with the guidelines on recommended immunization schedule in patients with inflammatory bowel disease: implications on public health policies

Infections

≤ 40 y

(n = 114)

41–60 y

(n = 127)

≥ 61 y

(n = 61)

Total

(n = 302)

P value

No. (%) (95% CI)

No. (%) (95% CI)

No. (%) (95% CI)

No. (%) (95% CI)

Measles, mumps, rubella

30 (26.3%) (18.2–4.4)

86 (67.7%) (58.8–75.7)

61 (100%) (94.1–100)

177 (58.6%) (52.8–64.2)

< 0.001

Varicella

60 (52.6%) (43.5–61.8)

55 (43.3%) (34.7–51.9)

19 (31.1%) (19.5–42.8)

134 (44.4%) (38.8–50.0)

0.006

Tetanus and diphtheria

35 (30.7%) (22.2–39.2)

57 (44.9%) (36.2–53.5)

29 (47.5%) (35.0–60.1)

121 (40.1%) (34.5–45.6)

0.016

Influenza

1 (0.9%) (0.0–2.6)

0 (0%) (0.0–0.0)

44 (72.1%) (60.9–83.4)

45 (14.9%) (10.9–18.9)

< 0.001

Pneumococcus

19 (16.7%) (9.8–23.5)

27 (21.3%) (14.4–28.4)

12 (19.7%) (9.7–29.6)

58 (19.2%) (14.8–23.6)

0.531

Meningococcus C

24 (21.1%) (13.6–28.5)

37 (29.1%) (21.2–37.0)

10 (16.4%) (7.1–25.7)

71 (23.5%) (18.7–28.3)

0.778

Hepatitis B

19 (16.7%) (9.8–23.5)

35 (27.6%) (19.8–35.3)

15 (24.6%) (13.8–35.4)

69 (22.8%) (18.1–27.6)

0.134

Hepatitis A

8 (7%) (2.3–11.7)

5 (3.9%) (0.6–7.3)

1 (1.6%) (0.0–4.8)

14 (4.6%) (2.3–7.0)

0.094

  1. CI Confidence interval.